Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions
Manager:
Search and click to pin securities to the top
Page 2 of 11
ANI PHARMACEUTICALS INC
Shares:317.5K
Value:$21.3M
Relay Therapeutics, Inc.
Shares:8.1M
Value:$21.1M
Compass Therapeutics, Inc.
Shares:11.1M
Value:$21.0M
ADMA BIOLOGICS, INC.
Shares:1.1M
Value:$20.8M
LENZ Therapeutics, Inc.
Shares:766.9K
Value:$19.7M
ASTRAZENECA PLC
Shares:250.0K
Value:$18.4M
Liquidia Corp
Shares:1.2M
Value:$17.7M
NEUROCRINE BIOSCIENCES INC
Shares:150.0K
Value:$16.6M
AVADEL PHARMACEUTICALS PLC
Shares:2.1M
Value:$16.4M
iTeos Therapeutics, Inc.
Shares:2.7M
Value:$16.1M
Meta Platforms, Inc.
Shares:27.6K
Value:$15.9M
GSK plc
Shares:400.0K
Value:$15.5M
NVIDIA CORP
Shares:142.6K
Value:$15.5M
Shares:270.0K
Value:$15.0M
Atea Pharmaceuticals, Inc.
Shares:4.8M
Value:$14.4M
Altimmune, Inc.
Shares:2.8M
Value:$13.8M
Zymeworks Inc.
Shares:1.1M
Value:$13.1M
Nkarta, Inc.
Shares:7.1M
Value:$13.0M
CARGO Therapeutics, Inc.
Shares:3.1M
Value:$12.5M
CYBIN INC.
Shares:1.8M
Value:$11.6M